Malignant MCA infarction: Pathophysiology and imaging for early diagnosis and management decisions

Cerebrovascular Diseases

Volumn 41, Issue 1-2, 2016, Pages 1-7

  Heiss, Wolf Dieter ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Brain edema; CT hypodensity; Decompressive hemicraniectomy; DW MRI lesion; Ischemic tissue damage; Malignant MCA infarction; Penumbra; PET tracer accumulation

Indexed keywords

BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN HERNIA; BRAIN TISSUE; CEREBRAL ARTERY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL (TOPIC); DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; EARLY DIAGNOSIS; HEADACHE; HEMIPARESIS; HUMAN; INTRACRANIAL HYPERTENSION; MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION; MEDICAL DECISION MAKING; MORTALITY; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROMONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN TISSUE LEVEL; PAPILLEDEMA; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TIGHT JUNCTION; TISSUE INJURY; TISSUE STRUCTURE; VOMITING; COMPLICATION; DECOMPRESSIVE CRANIECTOMY; DISEASE COURSE; EARLY INTERVENTION; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

OSMOTIC DIURETIC AGENT;

BLOOD-BRAIN BARRIER; BRAIN EDEMA; DECOMPRESSIVE CRANIECTOMY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; DIURETICS, OSMOTIC; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL HYPERTENSION; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84956730895     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000441627     Document Type: Review

References (54)

1. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. Malignant middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996; 53: 309-315.
2. White OB, Norris JW, Hachinski VC, Lewis A. Death in early stroke, causes and mechanisms. Stroke. 1979; 10: 743.
3. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke. 1981; 12: 474-477.
4. Treadwell SD, Thanvi B. Malignant middle cerebral artery (MCA) infarction: pathophysiology, diagnosis and management. Postgrad Med J. 2010; 86: 235-242.
5. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - The ischemic penumbra. Stroke. 1981; 12: 723-725.
6. Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol. 1983; 14: 294-301.
7. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol. 2006; 26: 1057-1083.
8. Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011; 31: 17-35.
9. Heiss WD. David Sherman lecture 2012: the role of positron emission tomography for translational research in stroke. Stroke. 2012; 43: 2520-2525.
10. Hoehn-Berlage M, Norris DG, Kohno K, Mies G, Leibfritz D, Hossmann KA. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab. 1995; 15: 1002-1011.
11. Wang CX, Shuaib A. Critical role of microvasculature basal lamina in ischemic brain injury. Prog Neurobiol. 2007; 83: 140-148.
12. Kniesel U, Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol. 2000; 20: 57-76.
13. Nielsen TH, Stahl N, Schalen W, Reinstrup P, Toft P, Nordstrom CH. Recirculation usually precedes malignant edema in middle cerebral artery infarcts. Acta Neurol Scand. 2012; 126: 404-410.
14. Lansberg MG, Thijs VN, OBrien MW, Ali JO, de Crespigny AJ, Tong DC, Moseley ME, Albers GW. Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. AJNR Am J Neuroradiol. 2001; 22: 637-644.
15. Torbey MT, Bosel J, Rhoney DH, Rincon F, Staykov D, Amar AP, Varelas PN, Juttler E, Olson D, Huttner HB, Zweckberger K, Sheth KN, Dohmen C, Brambrink AM, Mayer SA, Zaidat OO, Hacke W, Schwab S. Evidencebased guidelines for the management of large hemispheric infarction: a statement for health care professionals from the neurocritical care society and the German society for neuro-intensive care and emergency medicine. Neurocrit Care. 2015; 22: 146-164.
16. von Kummer R, Meyding-Lamade U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol. 1994; 15: 9-15; discussion 16-18.
17. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke. 1999; 30: 287-292.
18. Park J, Goh DH, Sung JK, Hwang YH, Kang DH, Kim Y. Timely assessment of infarct volume and brain atrophy in acute hemispheric infarction for early surgical decompression: strict cutoff criteria with high specificity. Acta Neurochir (Wien). 2012; 154: 79-85.
19. MacCallum C, Churilov L, Mitchell P, Dowling R, Yan B. Low alberta stroke program early CT score (ASPECTS) associated with malignant middle cerebral artery infarction. Cerebrovasc Dis. 2014; 38: 39-45.
20. Ryoo JW, Na DG, Kim SS, Lee KH, Lee SJ, Chung CS, Choi DS. Malignant middle cerebral artery infarction in hyperacute ischemic stroke: evaluation with multiphasic perfusion computed tomography maps. J Comput Assist Tomogr. 2004; 28: 55-62.
21. Foerch C, Lang JM, Krause J, Raabe A, Sitzer M, Seifert V, Steinmetz H, Kessler KR. Functional impairment, disability, and quality of life outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Neurosurg. 2004; 101: 248-254.
22. Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, Chalela JA, Abbur R, McGrade H, Christou I, Krieger DW. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke. 2001; 32: 2117-2123.
23. Lee SJ, Lee KH, Na DG, Byun HS, Kim YB, Shon YM, Cho SJ, Lee J, Chung CS, Hong SC. Multiphasic helical computed tomography predicts subsequent development of severe brain edema in acute ischemic stroke. Arch Neurol. 2004; 61: 505-509.
24. Kucinski T, Koch C, Grzyska U, Freitag HJ, Kromer H, Zeumer H. The predictive value of early CT and angiography for fatal hemispheric swelling in acute stroke. AJNR Am J Neuroradiol. 1998; 19: 839-846.
25. Kim H, Jin ST, Kim YW, Kim SR, Park IS, Jo KW. Predictors of malignant brain edema in middle cerebral artery infarction observed on CT angiography. J Clin Neurosci. 2015; 22: 554-560.
26. Oppenheim C, Samson Y, Manai R, Lalam T, Vandamme X, Crozier S, Srour A, Cornu P, Dormont D, Rancurel G, Marsault C. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke. 2000; 31: 2175-2181.
27. Thomalla G, Hartmann F, Juettler E, Singer OC, Lehnhardt FG, Kohrmann M, Kersten JF, Krutzelmann A, Humpich MC, Sobesky J, Gerloff C, Villringer A, Fiehler J, Neumann-Haefelin T, Schellinger PD, Rother J; Clinical Trial Net of the German Competence Network Stroke: Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: a prospective multicenter observational study. Ann Neurol 2010 68 435-445.
28. Kruetzelmann A, Hartmann F, Beck C, Juettler E, Singer OC, Kohrmann M, Kersten JF, Sobesky J, Gerloff C, Villringer A, Fiehler J, Neumann-Haefelin T, Schellinger PD, Rother J, Thomalla G; Clinical Trial Net of the German Competence Network Stroke: Combining magnetic resonance imaging within six-hours of symptom onset with clinical follow-up at 24 h improves prediction of malignant middle cerebral artery infarction. Int J Stroke 2014 9 210-214.
29. Beck C, Kruetzelmann A, Forkert ND, Juettler E, Singer OC, Kohrmann M, Kersten JF, Sobesky J, Gerloff C, Fiehler J, Schellinger PD, Rother J, Thomalla G. A simple brain atrophy measure improves the prediction of malignant middle cerebral artery infarction by acute DWI lesion volume. J Neurol. 2014; 261: 1097-1103.
30. Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D: 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke 1998 29 2556-2562.
31. Dohmen C, Bosche B, Graf R, Staub F, Kracht L, Sobesky J, Neveling M, Brinker G, Heiss WD. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke. 2003; 34: 2152-2158.
32. Karibe H, Zarow GJ, Graham SH, Weinstein PR. Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1994; 14: 620-627.
33. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke. 1998; 29: 2461-2466.
34. Georgiadis D, Schwarz S, Aschoff A, Schwab S. Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke. 2002; 33: 1584-1588.
35. Els T, Oehm E, Voigt S, Klisch J, Hetzel A, Kassubek J. Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke. Cerebrovasc Dis. 2006; 21: 79-85.
36. Neugebauer H, Kollmar R, Niesen WD, Bosel J, Schneider H, Hobohm C, Zweckberger K, Heuschmann PU, Schellinger PD, Juttler E; DEPTH-SOS Study Group; IGNITE Study Group: DEcompressive surgery Plus hypoTHermia for Space-Occupying Stroke (DEPTH-SOS): a protocol of a multicenter randomized controlled clinical trial and a literature review. Int J Stroke 2013 8 383-387.
37. Bereczki D, Fekete I, Prado GF, Liu M. Mannitol for acute stroke. Cochrane Database Syst Rev. 2007; 3: CD001153.
38. Righetti E, Celani MG, Cantisani T, Sterzi R, Boysen G, Ricci S. Glycerol for acute stroke. Cochrane Database Syst Rev. 2004; 2: CD000096.
39. Hauer EM, Stark D, Staykov D, Steigleder T, Schwab S, Bardutzky J. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med. 2011; 39: 1766-1772.
40. Qizilbash N, Lewington SL, Lopez-Arrieta JM. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev. 2002; 2: CD000064.
41. Scarcella G. Encephalomalacia simulating the clinical and radiological aspects of brain tumor; a report of 6 cases. J Neurosurg. 1956; 13: 278-292.
42. Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke. 2004; 35: 539-543.
43. Neugebauer H, Juttler E. Hemicraniectomy for malignant middle cerebral artery infarction: current status and future directions. Int J Stroke. 2014; 9: 460-467.
44. Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touze E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG; DECIMAL Investigators: Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL trial). Stroke 2007 38 2506-2517.
45. Juttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W; DESTINY Study Group: Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke 2007 38 2518-2525.
46. Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB; HAMLET Investigators: Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-Threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009 8 326-333.
47. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W; DECIMAL, DESTINY, and HAMLET Investigators: Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007 6 215-222.
48. Juttler E, Unterberg A, Woitzik J, Bosel J, Amiri H, Sakowitz OW, Gondan M, Schiller P, Limprecht R, Luntz S, Schneider H, Pinzer T, Hobohm C, Meixensberger J, Hacke W; DESTINY II Investigators: Hemicraniectomy in older patients with extensive middle-cerebral-Artery stroke. N Engl J Med 2014 370 1091-1100.
49. Suyama K, Horie N, Hayashi K, Nagata I. Nationwide survey of decompressive hemicraniectomy for malignant middle cerebral artery infarction in Japan. World Neurosurg. 2014; 82: 1158-1163.
50. Weil AG, Rahme R, Moumdjian R, Bouthillier A, Bojanowski MW. Quality of life following hemicraniectomy for malignant MCA territory infarction. Can J Neurol Sci. 2011; 38: 434-438.
51. Lu X, Huang B, Zheng J, Tao Y, Yu W, Tang L, Zhu R, Li S, Li L. Decompressive craniectomy for the treatment of malignant infarction of the middle cerebral artery. Sci Rep. 2014; 4: 7070.
52. Amorim RL, de Andrade AF, Gattas GS, Paiva WS, Menezes M, Teixeira MJ, Bor-Seng-Shu E. Improved hemodynamic parameters in middle cerebral artery infarction after decompressive craniectomy. Stroke. 2014; 45: 1375-1380.
53. Yang MH, Lin HY, Fu J, Roodrajeetsing G, Shi SL, Xiao SW. Decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: a systematic review and meta-Analysis. Surgeon. 2015; 13: 230-240.
54. Back L, Nagaraja V, Kapur A, Eslick GD. Role of decompressive hemicraniectomy in extensive middle cerebral artery strokes: a metaanalysis of randomised trials. Intern Med J. 2015; 45: 711-717.